SCHEMBL19987871

SCHEMBL19987871

CC(C)(C)[Si](C)(C)Oc1cc(OCc2ccccc2)ccc1C=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 4/20 0.46
MAOA P21397 3/20 0.46
NPC1 O15118 3/20 0.45
RAB9A P51151 3/20 0.45
ERN1 O75460 1/20 0.44
POLB P06746 1/20 0.43
MAPT P10636 1/20 0.43
CYP3A4 P08684 3/20 0.43
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43
HPGD P15428 1/20 0.43
HSD17B10 Q99714 1/20 0.43
IP6K1 Q92551 1/20 0.43
PTPN1 P18031 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
PKM P14618 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20742253 0.84 TUBB1 (0.44) MAOBMAOANPC1RAB9AERN1
SCHEMBL865350 0.81 MAOA (0.58) MAOBMAOANPC1RAB9AERN1
SCHEMBL19810818 0.81 ALDH1A1 (0.49) ERN1ALDH1A1CYP1A2CYP2C9L3MBTL1
SCHEMBL14572745 0.81 PTPN1 (0.47) MAOBALDH1A1PTPN1L3MBTL1CASP3
SCHEMBL435043 0.80 ALDH1A1 (0.61) MAOBMAOANPC1RAB9AERN1
SCHEMBL2901494 0.80 PPARG (0.45) MAOBMAOANPC1RAB9ACYP3A4
SCHEMBL2901054 0.80 MAOB (0.47) MAOBMAOANPC1RAB9ACYP3A4
SCHEMBL3370062 0.79 MAOB (0.52) MAOBMAOANPC1RAB9AERN1
SCHEMBL6836250 0.78 PPARG (0.55) MAOBMAOAERN1POLBMAPT
SCHEMBL1855277 0.78 MAOB (0.55) MAOBMAOANPC1RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107868091-B Meddigesin, derivatives thereof and preparation method thereof 怀特生技新药股份有限公司 2020-08-28 CN disclosed
US-10385061-B2 Medicarpin, its derivatives, manufacturing method thereof PHYTOHEALTH CORPORATION (TW) 2019-08-20 US disclosed
US-10385061-B2 Medicarpin, its derivatives, manufacturing method thereof PHYTOHEALTH CORPORATION (TW) 2019-08-20 US disclosed
US-20180086772-A1 MEDICARPIN, ITS DERIVATIVES, MANUFACTURING METHOD THEREOF PHYTOHEALTH CORPORATION (TW) 2018-03-29 US disclosed
US-20180086772-A1 MEDICARPIN, ITS DERIVATIVES, MANUFACTURING METHOD THEREOF PHYTOHEALTH CORPORATION (TW) 2018-03-29 US disclosed
EP-3299373-A2 MEDICARPIN, ITS DERIVATIVES, MANUFACTURING METHOD THEREOF PhytoHealth Corporation (TW) 2018-03-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180086772-A1 MEDICARPIN, ITS DERIVATIVES, MANUFACTURING METHOD THEREOF SHARPIN, TIPARP, MYADM MAOB 1213/4885MAOA 1263/4885NPC1 3703/4885
US-10385061-B2 Medicarpin, its derivatives, manufacturing method thereof SHARPIN, ATP6V1B1, REN MAOB 1618/4885MAOA 2027/4885NPC1 1881/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.